PHK
SBBP

Point72 Hong Kong’s Strongbridge Biopharma plc. SBBP Stock Holding History

Point72 Hong Kong’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,332
Closed -$6K – 2516
2021
Q1 		$6K Buy
+2,332
New +$7.04K ﹤0.01% 1646
2020
Q1 		– Sell
-900
Closed -$2K – 1507
2019
Q4 		$2K Buy
+900
New +$1.73K ﹤0.01% 1094

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Point72 Hong Kong's SBBP Position: Q2 2021 in Review

Point72 Hong Kong sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 2,332 shares — an estimated $6K sold.

Point72 Hong Kong first reported a position in SBBP in Q4 2019 and held it in 2 quarters. The position peaked at $6K in Q1 2021. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Point72 Hong Kong reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 2,332 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $6K.
  • Point72 Hong Kong first reported a position in Strongbridge Biopharma plc. in Q4 2019 and held it in 2 quarters.
  • Point72 Hong Kong's Strongbridge Biopharma plc. position peaked at $6K in Q1 2021.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.